Search
Close
Facebook-f Twitter Instagram Youtube Linkedin
Donate
  • Home
  • Who We Are
    • About Baylor Uganda
    • Governing Board
    • Partnerships
    • Where We Work
  • Focus Areas
    • Call Centre
    • HIV Care & Treatment
    • HIV Prevention
    • Health Systems Strengthening
    • Global Health Security
      • GHS Capacity Statement
      • Immunization Capacity
      • Surveillance
    • Key & Priority Populations
    • Gender
    • RMNCAH
    • Baylor Research
  • Projects
  • Resources
    • Annual Reports
    • Gallery
    • Research & Evaluations
    • Quality Improvement
    • Publications
      • News
      • Newsletters
      • Peer Review Articles
    • Conference Presentations
  • Jobs
  • Bids
  • Contact Us
Menu
  • Home
  • Who We Are
    • About Baylor Uganda
    • Governing Board
    • Partnerships
    • Where We Work
  • Focus Areas
    • Call Centre
    • HIV Care & Treatment
    • HIV Prevention
    • Health Systems Strengthening
    • Global Health Security
      • GHS Capacity Statement
      • Immunization Capacity
      • Surveillance
    • Key & Priority Populations
    • Gender
    • RMNCAH
    • Baylor Research
  • Projects
  • Resources
    • Annual Reports
    • Gallery
    • Research & Evaluations
    • Quality Improvement
    • Publications
      • News
      • Newsletters
      • Peer Review Articles
    • Conference Presentations
  • Jobs
  • Bids
  • Contact Us

Research & Evaluations

Search

Category

Status

Focus Area

Operational Research

COHORT

Prospective observational cohorts at the Baylor college of medicine children’s foundation – Uganda COE  

NOD

Novel and Optimized Diagnostics in Pediatric Tuberculosis in Kampala, Uganda

Mets Study

A cross sectional study of children and adolescent aged 6-19 years living with HIV and receiving ART to determine the …

Clinical Trials

IMPAACT 2009

Baylor-Uganda is part of this ongoing multi-centre parallel, observational cohort study among HIV-uninfected pregnant adolescents and young women (aged 16-24) since March 2019.

Clinical Trials

IMPAACT 2010

This is a phase III randomised open-label clinical trial assessing virologic efficacy and safety of Dolutegravir-containing versus Efavirenz-containing ART regimens in HIV-1 infected pregnant women and their infants.

Clinical Trials

Smile

Compares safety and antiretroviral effect of current standard ART to once daily intergrase inhibitor (INSTI) administered with darunavir/ritonavir (DRV/r) in …

1 2 3 4 5

Baylor College of Medicine Children’s Foundation-Uganda

Block 5 Mulago Hospital. P.O Box 72052, Kampala, Uganda
Tel: +256-417-119100/200, +256-312 119100
Toll Free: 0800204444 or 0800111011

Rwenzori Regional Office

Kakiza Road, Boma
Fort Portal City
Fort Portal.
Tel: 0483-422143

USAID LPHS - Eastern Region Activity

Regional office,
Plot 52,
Bungokho Road,
Senior Quarters, Mbale City

Bunyoro Regional Office

Rwenkobe Road, Hoima Municipality Plot 240 Bujumbura. Tel: +256417119100
Mail

Follow Us

© 2022 All Rights Reserved